Collection of Data on Adverse Events Related to Medicinal Products: A Survey Among Registries in the ENCePP Resources Database

por Plueschke, Kelly, Jonker, Carla, Strassmann, Valerie, Kurz, Xavier
Publicado 2022

Contribution of patient registries to regulatory decision making on rare diseases medicinal products in Europe

por Jonker, Carla J., Bakker, Elisabeth, Kurz, Xavier, Plueschke, Kelly
Publicado 2022

Contribution of Real‐World Evidence in European Medicines Agency's Regulatory Decision Making

por Bakker, Elisabeth, Plueschke, Kelly, Jonker, Carla J., Kurz, Xavier, Starokozhko, Viktoriia, Mol, Peter G. M.
Publicado 2022

Inhibitor development in previously untreated patients with severe haemophilia: A comparison of included patients and outcomes between a clinical study and a registry‐based study

por Jonker, Carla J., Oude Rengerink, Katrien, Hoes, Arno W., Mol, Peter G. M., van den Berg, H. Marijke
Publicado 2020

Registries supporting new drug applications

por Jonker, Carla J., van den Berg, H. Marijke, Kwa, Marcel S.G., Hoes, Arno W., Mol, Peter G.M.
Publicado 2017

Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders

por Jonker, Carla J., de Vries, Sieta T., van den Berg, H. Marijke, McGettigan, Patricia, Hoes, Arno W., Mol, Peter G. M.
Publicado 2021